Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-21-002615
Filing Date
2021-05-20
Accepted
2021-05-20 16:11:02
Documents
1
Period of Report
2021-05-19

Document Format Files

Seq Description Document Type Size
1 form4-05202021_040542.html 4  
1 form4-05202021_040542.xml 4 4461
  Complete submission text file 0001415889-21-002615.txt   6203
Mailing Address 950 WINTER STREET WALTHAM MA 02451
Business Address 950 WINTER STREET WALTHAM MA 02451 (858) 909-0749
Eloxx Pharmaceuticals, Inc. (Issuer) CIK: 0001035354 (see all company filings)

EIN.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address ALCHESTER HOUSE, LANGFORD LANE NORTH WENDLEBURY BICHESTER X0 OX6 ONS
Business Address
PAREKH RAJESH B (Reporting) CIK: 0001429930 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31326 | Film No.: 21944585